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Fetus monitoring in all its uterine development
stages is of major importance in perinatology, in
order to avoid spontaneous abortions, intrauterine
growth retardation and prematurity or perinatal
mortality äs a result of respiratory distress
syndrome.
Among the many available methods for fetal
monitoring (ultrasonography, Hormone tests
a.s.o.), the examination of the different enzymes'
activity in serum, urine and amniotic fluid is an
accurate index of the feto-placental unit function.
The serum CAP activity during normal and path-
ological pregnancies was studied in many works
to date. In contrast, there are no reports on the
enzymatic activity in pregnancy in malformed
uteri.
The aim of the present study is to investigate the
activity of cystine aminopeptidase (CAP) during
pregnancy in malformed uteri in comparison with
that in normal uteri.
l Material and Methods
The investigations were conducted in a group of
82 pregnant women between 20 and 31 years of
age, with congenital or acquired uterine mal-
formations, with a poor obstetrical history. This
group of patients comprised: 23 women with
uterus bicornus, 5 with Uterus dydelphis, 2 with
Uterus duplex, 13 with uterus arcuatus, and l with
uterus unicornis. We have included in our study
also the cases of so-called "acquired" malforma-
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tions, namely 7 women with uterus myomatosus
and 31 with intrauterine adhesions. In the patients'
past there were 145 second trimester abortions and
9 premature deliverieswithchildren who developed
respiratory distress syndrome. None of the women
ever delivered a yiable child.
During the whole period of pregnancy, we have
examined the serum CAP in aÜ patients, according
to the method of B ABUNA and YENEN [2], the
results being read on the colorimeter and expressed
in opticaldensity units. These results were compared
to those obtained by us in a previous study in a
number of 65 women belonging to a comparable
group of age and with normal pregnancy in a
normal uterus [4].
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Tab. I. Statisticaldata (NS : not sjgnificant, S: sfenificant)
Weeks of pregnancy 5
t value 0.31





























The serum activity of CAP is decreased in all cases
of malformed uterus, especially beginning with the
second trimester of pregnancy. These results are
presented on the Tab. I, where the statistical
data processed by means of the "Student test T"
are recorded.
The CAP activity is significantly decreased (2P <
0.05) äs compared to that in normal pregnancies.
The serum enzymatic values obtained in our study
are higher than those obtained by using the kinetic
method for serum CAP determination, described
by Oudheusden [12]. This new method, using äs
Substrate S-benzyl-L-cysteine-p-nitroanflide, can
reduce the assay time and therefore seems to be
more suitable.
3 Discussion
Almost all the authors agree nowadays that the
examination of the enzymatic activity, and
especially of the enzymes belonging to the amino-
peptidase group, may be of great help in perinat-
ology [l, 5, 6, 8, 9, 13], and moreover in comb-
ination with the parallel tests of the urinary
estrogen excretion [9, 10]. These tests are of
major importance in cases of pathological preg-
nancies and in patients with high risk pregnancies.
As it is very well known, CAP has the quality to
decompose the hypophisar oxytocin. This is the
Situation in normal uteri, but the decreased CAP
activity in malformed uteri raises some questions.
BENGTSSON [3] described the activity of a double,
nonpregnant uterus, and KEIN et al [10] the
motility of the malformed, nonpregnant uterus.
According to these authors' views, there is a
dissociation of the myometrial reactivity. In all
recordings both hemi-uteri reacted iri the same
way, but not simultaneously, to the same Stimuli.
If this occurs in nonpregnant malformed uteri,
it may be assumed that in pregnant malformed
uteri the Situation presents itself in a more drastic
way, moreover so äs the serum CAP activity is
decreased and cannot neutralize the hypophisar
oxytocin. This fact may result in uncoordinated
uterine contractions to which the uterine cervix
being not able to resist, can terminate in spont-
aneous abortions or prematüre deliveries. Even
if the pregnancy is not eliminatedj the contractions
may result in placental micro-ablations, ending by
placental insufficiency together with the in-
trauterine growth retardation of the fetus.
From the results of our work, we may clearly
conclude that in cases of uterine malformations,
congenital or acquired, the serum CAP activity is
decreased. Therefore, in all cases of uterine mal-
formation, although with a normal cervix, but in
which serum CAP activity isdiminished äs compared
to the normal value, it is suggested to perform a
cervical suture in order to avoid second trimester
abortions or perinatal mortality, äs ä result of
prematurity or respiratory 'distress syndrome.
In all 82 cases in which we have performed cercläge,
the pregnancies terminated by deliveries of viable
fetuses weighting from 2670 to 3950 gr.
Summaxy
The serum activity of cystine aminopeptidase (CAP) was
investigated during pregnancy in malformed uteri in
comparison to that in normal uterL The investigations
were conducted in 2 groups of women: the first consisted
of 82 pregnant women between 20 and 31 years of age
with congenital or acquired uterine malformations diag-
nosed by hysterography and in whom all previous preg-
nancies ended by second trimester abortion or premature
delivery. The second group comprised 65 pregnant women
with normal pregnancy in a normal uterus.
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Our results revealed that CAP activity is more decreased
in cases of pregnancies in malformed uteri äs compaied
to that in normal Uterus, especially beginning from the
second trimester of pregnancy. The decreased CAP activity
cannot neutralize the hypophisar oxytocin, thus causing
unco-ordinated contractions of the pregnant malformed
Uterus which may transform the pregnancy in a high risk
pregnancy resulting in spontaneousabortionsor premature
deliveries.
The only means to avoid these complications is to perform
cerclage in all cases of pregnancy in a malformed Uterus,
although with normal cervix, and a poor obstetrical history.
Keywords: Cystine aminopeptidase, pregnancy, uterine malformation
Zusammenfassung
Vergleichende Untersuchung über die Cystin-Amino-
Peptklase in der Schwangerschaft bei mißgebildeten und
normalen Uteri.
Bei Schwangeren mit Uterus-Mißbildungen wurde die
Cystin-Amino-Peptidase im Serum (CAP) untersucht
und mit den Werten bei normaler Schwangerschaft ver-
glichen. Unser Kollektiv bestand aus zwei Gruppen. Die
erste umfaßt 82 Schwangere im Alter von 20-31 Jahren
mit angeborenen oder erworbenen Uterus-Fehlbildungen.
Die Art der Mißbildung war zuvor durch Hysterographien
verifiziert worden. Alle früheren Schwangerschaften dieser
Patientinnen endeten durch Abort im mittleren Trimenon
oder als Frühgeburt. Die zweite Gruppe enthält 65
Schwangere mit normalem Uterus.
Unsere Untersuchungen zeigen, daß die Serum-CAP-Akti-
vität im mißgebildeten Uterus erniedrigt ist - besonders
ab zweitem Schwangerschaftsdrittel. Wir nehmen an,
daß die erniedrigte CAP-Aktivität das hypophysäre
Oxitozin nicht neutralisieren kann und es dadurch zu
unkoordinierten Kontraktionen im mißgebildeten Uterus
kommt. Die Folge ist möglicherweise eine Risikogravidi-
tät mit der Gefahr der vorzeitigen Beendigung durch
Abort oder Frühgeburt.
Die einzige Methode zur Verhütung dieser Komplikation
ist die Cerclage, die in allen Fällen von Uterus-Mißbildung
durchgeführt werden sollte, auch wenn der Zervix-Befund
normal ist und die Anamnese auf eine vorzeitige Schwan-
gerschaftsbeendigung schließen läßt.
Schlüsselwörter: Schwangerschaft, Uterus-Mißbildung, Cystin-Aminopeptidase.
Resume
Etüde comparative de l'activite de la CAP du serum en
cours de grossesse dans les Uterus normaux et malformes
Le present article porte sur Petude comparative de
Factivite de l'aminopeptidase de cystine (CAP) du serum
en cours de grossesse dans des Uterus normaux et mal-
formes.
Deux groupes de parturientes avaient ete selectionnes a
cet effet: Le premier se composait de 82 femmes enceintes
ägees de 20 a 31 ans et chez lesquelles on avait diagnostique
par hysterographie des malformations uterines congenitales
ou acquises et dont toutes les grossesses anterieures
s'etaient terminees par un avortement spontane au second
trimestre ou un accouchement premature. Le second
groupe reunissait 65 femmes enceintes ayant un Uterus et
une grossesse normaux.
Mots-cles: Aminopeptidase de cystine, grossesse, malformation uterine
Nos resultats ont montre que l'activite de CAP baisse da-
vantage dans les cas de grossesse dans un Uterus malforme,
surtout a partir du deuxieme trimestre de gravidite,
L'activite ralentie de CAP ne peut pas neutraliser l'oxyto-
cine hypophisaiie, provoquant ainsi des contractions non
coordonnees de l'uterus malforme enceint avec, pour
consequence, la transformation de la gravidite en grossesse
a haut risque et le declenchement d'un avortement
spontane ou d'un accouchement premature.
Le seul moyen d'eviter ces complications est d'appliquer
un cerclage dans tous les cas de grossesse dans un Uterus
malforme meme si le cervix est normal et si Panamnese
obstetrique est «chaigee».
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